Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Switching to Tenofovir Alafenamide Fumarate or Abacavir in Patients With Tenofovir Disoproxil Fumarate Associated eGFR Decline. A Randomized Trial.

NCT02957864 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT02957864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02957864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Switching to Tenofovir Alafenamide Fumarate or Abacavir in Patients With Tenofovir Disoproxil Fumarate Associated eGFR Decline. A Randomized Trial.
Lead sponsor
Erasmus Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2016
Completion date
September 30, 2020
Enrollment
80 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, renal insufficiency,chronic, therapeutic agent toxicity